Nosa Plugs AB ("Nosa Plugs" or "the Company") announced on 10 April 2026 that the Company is launching its full consumer portfolio on the French pharmacy market through an agreement with Phoenix OCP SAS ("OCP"), the French subsidiary of PHOENIX Group. The launch encompasses the Company's complete consumer range, including Nozoil, Odor Control, Microbial Control, and Smell Training. OCP holds a market share of approximately 30% of pharmacy purchasing in France and delivers to over 70% of the country's approximately 20,000 pharmacies.
In summary, Analyst Group views the launch of Nosa Plugs' full consumer portfolio on the French pharmacy market through OCP as an important milestone that significantly broadens the Company's presence in France. With an established B2B position through national and regional procurement frameworks, Nosa Plugs now enters the consumer channel through one of Europe's most extensive pharmacy distribution networks. The agreement is assessed to be in line with the Company's European expansion strategy and is expected to contribute to growing consumer revenues in France over time.
Read Analyst Group’s comment here
About Analyst Group: One of Sweden's leading equity research boutiques with focus on small and medium-sized listed companies.
Read more about Analyst Group
This is a press release from Analyst Group regarding the publication of a comment on Nosa Plugs. Readers may assume that Analyst Group has received compensation for making the comment. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.